Skip to main content
Clinical Trials/ISRCTN55416525
ISRCTN55416525
Completed
未知

The DAMPen-D study - improving the Detection, Assessment, Management, and Prevention of Delirium in hospices: co-design and feasibility study of a flexible and scalable implementation strategy to deliver guideline-adherent delirium care

niversity of Hull0 sites425 target enrollmentJune 30, 2021

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
niversity of Hull
Enrollment
425
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

2022 Protocol article in https://pubmed.ncbi.nlm.nih.gov/35831039/ (added 14/07/2022)

Registry
who.int
Start Date
June 30, 2021
End Date
February 14, 2023
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
niversity of Hull

Eligibility Criteria

Inclusion Criteria

  • Work package 1 (co\-design):
  • Not applicable
  • Work package 2 (feasibility study):
  • In\-patients admitted to study hospices
  • Work package 3 (process evaluation):
  • Hospice staff (healthcare assistants, nurses, allied health professionals, doctors, volunteers, care managers and executive board members) and volunteers directly and/or indirectly involved with the delivery of care

Exclusion Criteria

  • Does not meet inclusion criteria

Outcomes

Primary Outcomes

Not specified

Similar Trials